Vertex Pharmaceuticals said it stands ready to market hepatitis C drug telaprevir, under the brand name Incivek, and the company expected approval could come as early as the end of May.
Few doctors believe commercial support for CME should be eliminated, although a clear majority think corporate funding increases bias, according to a survey published in Archives of Internal Medicine.
Harvard affiliate Joslin Diabetes Center is mounting a CME research project with funding from a pharmaceutical company whose products are tangential to the therapeutic area.
Wolters Kluwer Pharma Solutions will get a new CEO following the retirement of the pharmacy data and analytics firm’s former head honcho, Mark Spiers, in April.
The budgets and the personnel devoted to the generation of customer insight are shrinking, putting more pressure on market research functions to deliver value supportive of business priorities.